paclitaxel injection, powder, lyophilized, for suspension
hbt labs, inc. - paclitaxel (unii: p88xt4is4d) (paclitaxel - unii:p88xt4is4d) - paclitaxel protein-bound particles for injectable suspension (albumin-bound) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. prior therapy should have included an anthracycline unless clinically contraindicated. paclitaxel protein-bound particles for injectable suspension (albumin-bound) is indicated for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. paclitaxel protein-bound particles for injectable suspension (albumin-bound) is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine. paclitaxel protein-bound particles for injectable suspension (albumin-bound) is contraindicated in patients with: - baseline neutrophil counts of < 1,500 cells/mm3 [see warnings and precaut
paclitaxel ebewe paclitaxel 150 mg/25 ml concentrated injection vial
sandoz pty ltd - paclitaxel, quantity: 150 mg - injection, concentrated - excipient ingredients: ethanol; peg-35 castor oil - primary treatment of ovarian cancer in combination with a platinum agent. treatment of metastatic ovarian cancer and breast cancer, after failure of standard therapy. treatment of non-small cell lung cancer (nsclc). adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. treatment of metastatic cancer of the breast, in combination with trastuzumab (herceptin), in patients who have tumours that overexpress her-2 and who have not received previous chemotherapy for their previous metastatic disease.
paclitaxel ebewe paclitaxel 100 mg/16.7 ml concentrated injection vial
sandoz pty ltd - paclitaxel, quantity: 100 mg - injection, concentrated - excipient ingredients: peg-35 castor oil; ethanol - primary treatment of ovarian cancer in combination with a platinum agent. treatment of metastatic ovarian cancer and breast cancer, after failure of standard therapy. treatment of non-small cell lung cancer (nsclc). adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. treatment of metastatic cancer of the breast, in combination with trastuzumab (herceptin), in patients who have tumours that overexpress her-2 and who have not received previous chemotherapy for their previous metastatic disease.
paclitaxel ebewe paclitaxel 30 mg/5 ml concentrated injection vial
sandoz pty ltd - paclitaxel, quantity: 30 mg - injection, concentrated - excipient ingredients: peg-35 castor oil; ethanol - primary treatment of ovarian cancer in combination with a platinum agent. treatment of metastatic ovarian cancer and breast cancer, after failure of standard therapy. treatment of non-small cell lung cancer (nsclc). adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. treatment of metastatic cancer of the breast, in combination with trastuzumab (herceptin), in patients who have tumours that overexpress her-2 and who have not received previous chemotherapy for their previous metastatic disease.
paclitaxel
accord healthcare limited - paclitaxel - concentrate for soln for inf - 6 mg/ml - paclitaxel
paclitaxel 6 mg/ml concentrate for solution for infusion
fresenius kabi limited - paclitaxel - concentrate for solution for infusion - 6 milligram(s)/millilitre - taxanes; paclitaxel
paclitaxel 6mg/ml concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - paclitaxel - concentrate for solution for infusion - paclitaxel 6 mg/ml - antineoplastic agents
paclitaxel 6mg/ml concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - paclitaxel - concentrate for solution for infusion - paclitaxel 6 mg - antineoplastic agents
paclitaxel 6mg/ml concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - paclitaxel - concentrate for solution for infusion - paclitaxel 6 mg/ml - antineoplastic agents
paclitaxel-teva
pharmachemie b.v. swensweg 5 - paclitaxel - concentrate for solution for infusion - 6mg/ml